Outcomes after Thrombectomy for Minor Stroke: A Meta-Analysis

Xiao Wu1, Mihir Khunte1, Sam Payabvash1

  • 1Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut, USA.

World Neurosurgery
|December 28, 2020
PubMed
Abstract

Insights

Mechanical thrombectomy (MT) shows potential benefits for minor strokes with large-vessel occlusion, but results vary. Further randomized controlled trials are needed due to significant heterogeneity and selection bias in current studies.

Area of Science:

  • Neurology
  • Interventional Neuroradiology
  • Stroke Medicine

Background:

  • Minor stroke patients with large-vessel occlusion (LVO) represent a significant clinical challenge.
  • Optimal treatment strategies, including mechanical thrombectomy (MT) versus medical management, require further elucidation.

Purpose of the Study:

  • To compare the outcomes of mechanical thrombectomy (MT) against medical management in patients experiencing minor stroke symptoms due to large-vessel occlusion.

Main Methods:

  • A comprehensive meta-analysis was conducted on 14 studies involving 2134 patients.
  • Studies included MT as a standalone therapy or in combination with intravenous thrombolysis.
  • Outcomes analyzed included excellent/good functional outcomes, mortality, and symptomatic intracranial hemorrhage (sICH).

Main Results:

  • Immediate MT showed trends towards better excellent and good outcomes compared to best medical management, but with a higher incidence of sICH.
  • MT compared to medical management (without thrombectomy) demonstrated similar excellent outcomes but increased mortality and sICH rates.
  • Pooled data from all MT studies indicated 58.7% excellent outcomes, 76.2% good outcomes, 6.82% mortality, and 3.23% sICH.

Conclusions:

  • Significant selection bias and heterogeneity exist across studies, impacting baseline characteristics and treatment protocols.
  • Variations in patient selection, reperfusion rates, and MT criteria necessitate caution in interpreting current evidence.
  • A high-quality randomized controlled trial is crucial to definitively establish the efficacy and safety of MT for minor strokes with LVO.